4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-021872
Options or other derivatives
- Interim CEO & General Counsel acquired 187,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Vogt Frederick G · Interim CEO & General Counsel
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-05 | Grant or award : show line 1 in the form Restricted Stock Units | +187,500 | 187,500 | D |
Loading xslF345X05/tm258333-10_4seq1.xml…